rosette sep human monocyte enrichment kit (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
rosette sep human monocyte enrichment kit
Rosette Sep Human Monocyte Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosette-sep+kit/rosettesep+human+monocyte+enrichment+cocktail/pm38535625-251-45-51
Average 90 stars, based on 1 article reviews
Rosette Sep Human Monocyte Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosette-sep+kit/rosettesep+human+monocyte+enrichment+cocktail/pm38535625-251-45-51
Average 90 stars, based on 1 article reviews
rosette sep human monocyte enrichment kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Selection:Article Title: B-cell reduction using CD37-specific and CD20-specific binding molecules Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit 11 (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Article Snippet: 15 CLL B cells were isolated from freshly donated blood using ficoll density gradient centrifugation (Ficoll-Paque Plus; Amersham Biosciences, Piscataway, NJ) with enrichment using the Article Title: Comparative Assessment of Clinically Utilized CD20-directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK cell, Monocyte and Macrophage Properties Article Snippet: Enriched CLL fractions were prepared with the use of the Article Title: T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients Article Snippet: Isolation of B cells B cells were isolated from PBMCs using the B-cell isolation kit (Miltenyi Biotec) or the Article Title: CD37 immunotherapeutics and uses thereof Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit II (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Arsenic trioxide and Ascorbic Acid Demonstrates Promising Activity against Primary Human CLL Cells in Vitro Article Snippet: Enriched B-lymphocyte fractions were prepared by using MACS negative selection kit (Miltenyi Biotec, Auburn, CA) or by Article Title: Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies Article Snippet: Enriched CLL B cells were prepared with the use of the Cell Isolation:Article Title: B-cell reduction using CD37-specific and CD20-specific binding molecules Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit 11 (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Article Snippet: 15 CLL B cells were isolated from freshly donated blood using ficoll density gradient centrifugation (Ficoll-Paque Plus; Amersham Biosciences, Piscataway, NJ) with enrichment using the Article Title: Comparative Assessment of Clinically Utilized CD20-directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK cell, Monocyte and Macrophage Properties Article Snippet: Enriched CLL fractions were prepared with the use of the Article Title: T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients Article Snippet: Isolation of B cells B cells were isolated from PBMCs using the B-cell isolation kit (Miltenyi Biotec) or the Article Title: CD37 immunotherapeutics and uses thereof Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit II (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Arsenic trioxide and Ascorbic Acid Demonstrates Promising Activity against Primary Human CLL Cells in Vitro Article Snippet: Enriched B-lymphocyte fractions were prepared by using MACS negative selection kit (Miltenyi Biotec, Auburn, CA) or by Article Title: Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies Article Snippet: Enriched CLL B cells were prepared with the use of the Isolation:Article Title: B-cell reduction using CD37-specific and CD20-specific binding molecules Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit 11 (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Article Snippet: 15 CLL B cells were isolated from freshly donated blood using ficoll density gradient centrifugation (Ficoll-Paque Plus; Amersham Biosciences, Piscataway, NJ) with enrichment using the Article Title: Comparative Assessment of Clinically Utilized CD20-directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK cell, Monocyte and Macrophage Properties Article Snippet: Enriched CLL fractions were prepared with the use of the Article Title: T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients Article Snippet: Isolation of B cells B cells were isolated from PBMCs using the B-cell isolation kit (Miltenyi Biotec) or the Article Title: CD37 immunotherapeutics and uses thereof Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit II (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Arsenic trioxide and Ascorbic Acid Demonstrates Promising Activity against Primary Human CLL Cells in Vitro Article Snippet: Enriched B-lymphocyte fractions were prepared by using MACS negative selection kit (Miltenyi Biotec, Auburn, CA) or by Article Title: Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies Article Snippet: Enriched CLL B cells were prepared with the use of the Gradient Centrifugation:Article Title: B-cell reduction using CD37-specific and CD20-specific binding molecules Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit 11 (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Article Snippet: 15 CLL B cells were isolated from freshly donated blood using ficoll density gradient centrifugation (Ficoll-Paque Plus; Amersham Biosciences, Piscataway, NJ) with enrichment using the Article Title: Comparative Assessment of Clinically Utilized CD20-directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK cell, Monocyte and Macrophage Properties Article Snippet: Enriched CLL fractions were prepared with the use of the Article Title: T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients Article Snippet: Isolation of B cells B cells were isolated from PBMCs using the B-cell isolation kit (Miltenyi Biotec) or the Article Title: CD37 immunotherapeutics and uses thereof Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit II (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Arsenic trioxide and Ascorbic Acid Demonstrates Promising Activity against Primary Human CLL Cells in Vitro Article Snippet: Enriched B-lymphocyte fractions were prepared by using MACS negative selection kit (Miltenyi Biotec, Auburn, CA) or by Article Title: Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies Article Snippet: Enriched CLL B cells were prepared with the use of the Magnetic Cell Separation:Article Title: B-cell reduction using CD37-specific and CD20-specific binding molecules Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit 11 (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Article Snippet: 15 CLL B cells were isolated from freshly donated blood using ficoll density gradient centrifugation (Ficoll-Paque Plus; Amersham Biosciences, Piscataway, NJ) with enrichment using the Article Title: Comparative Assessment of Clinically Utilized CD20-directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK cell, Monocyte and Macrophage Properties Article Snippet: Enriched CLL fractions were prepared with the use of the Article Title: T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients Article Snippet: Isolation of B cells B cells were isolated from PBMCs using the B-cell isolation kit (Miltenyi Biotec) or the Article Title: CD37 immunotherapeutics and uses thereof Article Snippet: For those samples with less than 90% B cells, negative selection was applied to deplete non-B cells using B cell Isolation Kit II (Miltenyi Biotec, Auburn, Calif.) or by Article Title: Arsenic trioxide and Ascorbic Acid Demonstrates Promising Activity against Primary Human CLL Cells in Vitro Article Snippet: Enriched B-lymphocyte fractions were prepared by using MACS negative selection kit (Miltenyi Biotec, Auburn, CA) or by Article Title: Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies Article Snippet: Enriched CLL B cells were prepared with the use of the |
